Case number 2:17-cv-00071
Aralez Pharmaceuticals Inc. et al v. Teva Pharmaceuticals USA, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 1, 2017 | 19 | Amended Complaint* (1) |
| Jan 25, 2017 | 1 | Civil Cover Sheet (1) |
| Jan 25, 2017 | 2 | Exhibit A - '907 Patent (20) |
| Jan 25, 2017 | 1 | Main Document (20) |
| Jan 25, 2017 | 3 | Exhibit B - '741 Patent (21) |
| Jan 25, 2017 | 1 | Civil Cover Sheet (1) |
| Jan 25, 2017 | 2 | Corporate Disclosure Statement (2) |
| Jan 25, 2017 | 4 | Exhibit C - '439 Patent (24) |
| Jan 25, 2017 | 2 | Exhibit A - '907 Patent (20) |
| Jan 25, 2017 | 5 | Exhibit D - '214 Patent (46) |
| Jan 25, 2017 | 3 | Exhibit B - '741 Patent (21) |
| Jan 25, 2017 | 2 | Corporate Disclosure Statement (2) |
| Jan 25, 2017 | 4 | Exhibit C - '439 Patent (24) |
| Jan 25, 2017 | 5 | Exhibit D - '214 Patent (46) |
| Jan 25, 2017 | 1 | Main Document (20) |
| Jan 25, 2017 | 5 | Notice of Attorney Appearance (2) |
| Jan 25, 2017 | 1 | Civil Cover Sheet (1) |
| Jan 25, 2017 | 1 | Main Document (20) |
| Jan 25, 2017 | 2 | Exhibit A - '907 Patent (20) |
| Jan 25, 2017 | 3 | Exhibit B - '741 Patent (21) |
| Jan 25, 2017 | 4 | Exhibit C - '439 Patent (24) |
| Jan 25, 2017 | 5 | Exhibit D - '214 Patent (46) |
| Jan 25, 2017 | 2 | Corporate Disclosure Statement (2) |
| Jan 25, 2017 | 5 | Notice of Attorney Appearance (2) |
| Jan 25, 2017 | 1 | Main Document (20) |
| Jan 25, 2017 | 2 | Corporate Disclosure Statement (2) |
| Jan 25, 2017 | 1 | Civil Cover Sheet (1) |
| Jan 25, 2017 | 2 | Exhibit A - '907 Patent (20) |
| Jan 25, 2017 | 3 | Exhibit B - '741 Patent (21) |
| Jan 25, 2017 | 4 | Exhibit C - '439 Patent (24) |
| Jan 25, 2017 | 5 | Exhibit D - '214 Patent (46) |
| Jan 25, 2017 | 5 | Notice of Attorney Appearance (2) |
| Jan 25, 2017 | 5 | Notice of Attorney Appearance (2) |
| Jan 23, 2017 | 1 | Complaint* (1) |
